CRIS Current Research Information System

ISIDORI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.208
AS - Asia 1.876
EU - Europa 1.421
AF - Africa 95
SA - Sud America 91
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
Totale 5.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.182
SG - Singapore 525
VN - Vietnam 487
CN - Cina 449
GB - Regno Unito 297
SE - Svezia 244
DE - Germania 194
IT - Italia 175
HK - Hong Kong 116
FR - Francia 95
IN - India 94
UA - Ucraina 67
RU - Federazione Russa 66
BR - Brasile 64
IE - Irlanda 62
NL - Olanda 55
FI - Finlandia 38
JP - Giappone 37
TG - Togo 36
KR - Corea 29
ZA - Sudafrica 28
BG - Bulgaria 27
CH - Svizzera 25
JO - Giordania 20
EE - Estonia 19
ID - Indonesia 19
CA - Canada 18
CI - Costa d'Avorio 17
EU - Europa 16
BE - Belgio 15
PH - Filippine 12
TR - Turchia 12
BD - Bangladesh 11
TH - Thailandia 11
GR - Grecia 9
AR - Argentina 8
IR - Iran 8
TW - Taiwan 8
IQ - Iraq 7
SA - Arabia Saudita 7
ES - Italia 6
LB - Libano 6
MX - Messico 6
PL - Polonia 6
SC - Seychelles 6
CO - Colombia 5
UZ - Uzbekistan 5
AU - Australia 4
EC - Ecuador 4
PY - Paraguay 4
RO - Romania 4
AT - Austria 3
HR - Croazia 3
MY - Malesia 3
PE - Perù 3
PK - Pakistan 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
MA - Marocco 2
OM - Oman 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GI - Gibilterra 1
HU - Ungheria 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
MG - Madagascar 1
MK - Macedonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 5.711
Salva come PNG Salva come JPEG
Città #
Singapore 371
Ashburn 274
Southend 251
Chandler 190
Fairfield 179
Dong Ket 128
San Jose 120
Woodbridge 119
Hong Kong 106
Houston 103
Wilmington 102
Seattle 99
Ho Chi Minh City 96
Ann Arbor 88
Hanoi 87
Santa Clara 77
Beijing 76
Cambridge 76
Hefei 73
Princeton 63
Dublin 60
New York 48
Jacksonville 45
Boardman 40
Los Angeles 40
Lomé 36
Tokyo 31
Lauterbourg 29
Helsinki 27
Nanjing 27
Sofia 27
Westminster 27
Berlin 25
Bologna 24
Seoul 24
Bremen 23
Bern 22
Hyderabad 22
Frankfurt am Main 21
Amman 20
Padova 18
Abidjan 17
Milan 17
Munich 16
Brussels 15
Da Nang 15
San Diego 15
Turin 15
Haiphong 14
Dallas 13
Jinan 13
Norwalk 12
Buffalo 11
Guangzhou 10
Zhengzhou 10
Chicago 9
Redmond 9
Redondo Beach 9
Saint Petersburg 9
Changsha 8
Jakarta 8
Jiaxing 8
Mülheim 8
Orem 8
Tianjin 8
Bengaluru 7
Council Bluffs 7
Olalla 7
Salsomaggiore Terme 7
Shenyang 7
São Paulo 7
Toronto 7
Turku 7
Yubileyny 7
Hebei 6
London 6
Nanchang 6
Rome 6
Bangkok 5
Changchun 5
Des Moines 5
Falls Church 5
Mahé 5
Montreal 5
Phoenix 5
San Francisco 5
Tashkent 5
Verona 5
Amsterdam 4
Biên Hòa 4
Brooklyn 4
Chengdu 4
Chennai 4
Chongqing 4
Falkenstein 4
Foshan 4
Hangzhou 4
Hải Dương 4
Istanbul 4
Johannesburg 4
Totale 3.776
Salva come PNG Salva come JPEG
Nome #
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. 267
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. 250
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 228
NUCLEOFECTION IS AN EFFICIENT NON-VIRAL TRANSFECTION TECHNIQUE FOR HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS. 225
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients 220
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 213
Genetic profiling in acute myeloid leukemia: a path to predicting treatment outcome 209
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 208
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas 206
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study 204
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? 203
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts 190
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia 187
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients 187
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study 184
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. 180
Dendritic cell differentiation. 179
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 175
Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. 173
Stem cell mobilization and collection in patients with liver cirrhosis. 165
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 165
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 154
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. 154
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML 153
Consolidation therapy for adult acute myeloid leukemia: A systematic analysis according to evidence based medicine 141
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma 139
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia 137
Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling 136
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 128
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice 127
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 117
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 77
Two more inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript: Clinical and molecular findings [4] 65
The role of menin inhibitors in acute myeloid leukemia 52
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 20
Totale 5.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021198 0 0 0 0 0 0 0 0 0 21 38 139
2021/2022658 55 26 37 75 51 39 22 37 34 62 130 90
2022/2023791 89 110 42 107 40 65 20 50 129 16 63 60
2023/2024261 16 42 18 32 14 79 7 12 2 16 8 15
2024/2025720 39 73 46 74 116 30 52 9 28 69 25 159
2025/20261.789 146 144 144 169 240 104 172 94 435 141 0 0
Totale 5.818